BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karreman MC, Luime JJ, Hazes JMW, Weel AEAM. The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis. 2017;11:631-642. [PMID: 28453761 DOI: 10.1093/ecco-jcc/jjw199] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 So J, Tam LS. Gut Microbiome and Its Interaction with Immune System in Spondyloarthritis. Microorganisms 2020;8:E1727. [PMID: 33158167 DOI: 10.3390/microorganisms8111727] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Hanzel J, Ma C, Casteele NV, Khanna R, Jairath V, Feagan BG. Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease. Drugs 2021;81:333-47. [PMID: 33400241 DOI: 10.1007/s40265-020-01460-3] [Reference Citation Analysis]
3 Felice C, Leccese P, Scudeller L, Lubrano E, Cantini F, Castiglione F, Gionchetti P, Orlando A, Salvarani C, Scarpa R, Vecchi M, Olivieri I, Armuzzi A; Italian SpA-IBD Expert Panel Group. Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis. Clin Exp Immunol 2019;196:123-38. [PMID: 30554407 DOI: 10.1111/cei.13246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Derakhshan MH, Goodson NJ, Packham J, Sengupta R, Molto A, Marzo-Ortega H, Siebert S; BRITSpA and the ASAS-COMOSPA Investigators. Association of Diverticulitis with Prolonged Spondyloarthritis: An Analysis of the ASAS-COMOSPA International Cohort. J Clin Med 2019;8:E281. [PMID: 30813544 DOI: 10.3390/jcm8030281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Bartels LE, Pedersen AB, Kristensen NR, Vilstrup H, Stengaard-Pedersen K, Dahlerup JF. A positive Helicobacter pylori test is associated with low spondylarthritis incidence in a Danish historical cohort study. Rheumatol Int 2020;40:359-66. [PMID: 31802207 DOI: 10.1007/s00296-019-04487-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Benfaremo D, Luchetti MM, Gabrielli A. Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs. J Immunol Res 2019;2019:8630871. [PMID: 31276001 DOI: 10.1155/2019/8630871] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
7 Märker-Hermann E. [Update: enterogenic spondylarthritis]. Z Rheumatol 2021;80:539-51. [PMID: 34046687 DOI: 10.1007/s00393-021-01014-2] [Reference Citation Analysis]
8 Gill T, Rosenbaum JT. Putative Pathobionts in HLA-B27-Associated Spondyloarthropathy. Front Immunol 2020;11:586494. [PMID: 33537028 DOI: 10.3389/fimmu.2020.586494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hokama A, Miyagi T, Takeichi Y, Uema E, Takehara S, Ohira T, Iraha A, Kinjo T, Fujita J. Sausage-like fingers in Crohn's disease. Intest Res 2020;18:341-2. [PMID: 32446295 DOI: 10.5217/ir.2020.00036] [Reference Citation Analysis]
10 Tambuwala MM, Khan MN, Thompson P, McCarron PA. Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis. Drug Deliv Transl Res 2019;9:14-24. [PMID: 30430451 DOI: 10.1007/s13346-018-00597-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
11 Parfenov AI, Kagramanova AV, Knyazev OV. [Systemic manifestations of inflammatory bowel diseases]. Ter Arkh 2020;92:4-11. [PMID: 32598711 DOI: 10.26442/00403660.2020.02.000535] [Reference Citation Analysis]
12 Falloon K, Cohen B, Ananthakrishnan AN, Barnes EL, Bhattacharya A, Colombel JF, Cross RK, Driscoll MS, Fernandez AP, Ha C, Herfarth H, Horst S, Hou J, Husni ME, Kroshinsky D, Kuhn KA, Lowder CY, Martin G, Parikh D, Sayed CJ, Schocket L, Siaton BC, Vedak P, Weisman MH, Rieder F. A United States expert consensus to standardise definitions, follow-up, and treatment targets for extra-intestinal manifestations in inflammatory bowel disease. Aliment Pharmacol Ther 2022;55:1179-91. [PMID: 35277863 DOI: 10.1111/apt.16853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Zhang M, Bai X, Cao W, Ji J, Wang L, Yang Y, Yang H. The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence. Front Immunol 2021;12:677957. [PMID: 34335579 DOI: 10.3389/fimmu.2021.677957] [Reference Citation Analysis]
14 Shen J, Yang L, You K, Chen T, Su Z, Cui Z, Wang M, Zhang W, Liu B, Zhou K, Lu H. Indole-3-Acetic Acid Alters Intestinal Microbiota and Alleviates Ankylosing Spondylitis in Mice. Front Immunol 2022;13:762580. [DOI: 10.3389/fimmu.2022.762580] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bernstein CN, Benchimol EI, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Kaplan GG. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD. J Can Assoc Gastroenterol 2019;2:S73-80. [PMID: 31294387 DOI: 10.1093/jcag/gwy053] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
16 Queiro R, Rodríguez-Caminero S, Riestra S, de Francisco R, Pérez-Martínez I, Ballina J. Performance of Two Screening Questionnaires for Inflammatory Arthritis in Patients with Inflammatory Bowel Disease. Biomed Res Int 2018;2018:8618703. [PMID: 29854801 DOI: 10.1155/2018/8618703] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
17 Rizzello F, Olivieri I, Armuzzi A, Ayala F, Bettoli V, Bianchi L, Cimino L, Costanzo A, Cristaudo A, D'Angelo S, Daperno M, Fostini AC, Galeazzi M, Gilio M, Gionchetti P, Gisondi P, Lubrano E, Marchesoni A, Offidani A, Orlando A, Pugliese D, Salvarani C, Scarpa R, Vecchi M, Girolomoni G. Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease. Adv Ther 2018;35:545-62. [PMID: 29516409 DOI: 10.1007/s12325-018-0672-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
18 Evans J, Sapsford M, McDonald S, Poole K, Raine T, Jadon DR. Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review. Ther Adv Musculoskelet Dis 2021;13:1759720X21996973. [PMID: 33786068 DOI: 10.1177/1759720X21996973] [Reference Citation Analysis]
19 Kumar A, Lukin D, Battat R, Schwartzman M, Mandl LA, Scherl E, Longman RS. Defining the phenotype, pathogenesis and treatment of Crohn's disease associated spondyloarthritis. J Gastroenterol 2020;55:667-78. [PMID: 32367294 DOI: 10.1007/s00535-020-01692-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Fragoulis GE, Liava C, Daoussis D, Akriviadis E, Garyfallos A, Dimitroulas T. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment. World J Gastroenterol 2019; 25(18): 2162-2176 [PMID: 31143068 DOI: 10.3748/wjg.v25.i18.2162] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 35] [Article Influence: 15.3] [Reference Citation Analysis]
21 Jang HJ, Kang B, Choe BH. The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults. Transl Pediatr 2019;8:4-15. [PMID: 30881893 DOI: 10.21037/tp.2019.01.06] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
22 Gerenli N, Sozeri B, Kalin S, Kirmizibekmez H, Celtik C. Sacroiliac joint involvement in children with inflammatory bowel diseases. North Clin Istanb 2022;9:57-63. [PMID: 35340318 DOI: 10.14744/nci.2021.24572] [Reference Citation Analysis]
23 Kavadichanda CG, Geng J, Bulusu SN, Negi VS, Raghavan M. Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B*27 Connection. Front Immunol 2021;12:601518. [PMID: 33763060 DOI: 10.3389/fimmu.2021.601518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Felice C, Pugliese D, Papparella LG, Pizzolante F, Onori E, Gasbarrini A, Rapaccini GL, Guidi L, Armuzzi A. Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases. Expert Review of Clinical Immunology 2018;14:751-9. [DOI: 10.1080/1744666x.2018.1513329] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Jansen FM, Vavricka SR, den Broeder AA, de Jong EM, Hoentjen F, van Dop WA. Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes. United European Gastroenterol J 2020;8:1031-44. [PMID: 32921269 DOI: 10.1177/2050640620958902] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Fauny M, Cohen N, Morizot C, Leclerc-Jacob S, Wendling D, Lux G, Laurent V, Blum A, Netter P, Baumann C, Chary-Valckenaere I, Peyrin-Biroulet L, Loeuille D. Low Back Pain and Sacroiliitis on Cross-Sectional Abdominal Imaging for Axial Spondyloarthritis Diagnosis in Inflammatory Bowel Diseases. Inflamm Intest Dis 2020;5:124-31. [PMID: 32999885 DOI: 10.1159/000507930] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Sanz Sanz J, Juanola Roura X, Seoane-mato D, Montoro M, Gomollón F. Criterios de cribado de enfermedad inflamatoria intestinal y espondiloartritis para derivación de pacientes entre Reumatología y Gastroenterología. Gastroenterología y Hepatología 2018;41:54-62. [DOI: 10.1016/j.gastrohep.2017.03.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Barnett R, Ingram T, Sengupta R. Axial spondyloarthritis 10 years on: still looking for the lost tribe. Rheumatology (Oxford) 2020;59:iv25-37. [PMID: 33053196 DOI: 10.1093/rheumatology/keaa472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
29 Sakellariou G, Schiepatti A, Scalvini D, Lusetti F, Fazzino E, Biagi F, Montecucco C. Musculoskeletal Ultrasound to Identify Subclinical Joint and Periarticular Involvement in Patients With Inflammatory Bowel Disease: A Systematic Literature Review. Front Med 2022;9:919521. [DOI: 10.3389/fmed.2022.919521] [Reference Citation Analysis]
30 Coto P, Riestra S, Rozas P, Señaris A, Queiro R. Improving the standard of care for patients with spondyloarthritis-related immune inflammatory conditions: results of a Delphi study and proposal for early detection. Ther Adv Chronic Dis 2020;11:2040622320904295. [PMID: 32110287 DOI: 10.1177/2040622320904295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Feng J, Li J, Li Y, Jin Y, Du F, Chen X. Elevated Serum D-Dimer May Reflect the Presence of Gut Inflammation in Spondyloarthritis. Front Med 2022;8:816422. [DOI: 10.3389/fmed.2021.816422] [Reference Citation Analysis]
32 Maul J. Rheumatologische Erkrankungen und der Gastrointestinaltrakt. Aktuelle Rheumatologie 2021;46:561-71. [DOI: 10.1055/a-1638-7663] [Reference Citation Analysis]
33 Hunter ML, Knuiman MW, Musk BAW, Hui J, Murray K, Beilby JP, Hillman DR, Hung J, Newton RU, Bucks RS, Straker L, Walsh JP, Zhu K, Bruce DG, Eikelboom RH, Davis TME, Mackey DA, James AL. Prevalence and patterns of multimorbidity in Australian baby boomers: the Busselton healthy ageing study. BMC Public Health 2021;21:1539. [PMID: 34380465 DOI: 10.1186/s12889-021-11578-y] [Reference Citation Analysis]
34 Kuret T, Sodin-šemrl S, Leskošek B, Ferk P. Single Cell RNA Sequencing in Autoimmune Inflammatory Rheumatic Diseases: Current Applications, Challenges and a Step Toward Precision Medicine. Front Med 2022;8:822804. [DOI: 10.3389/fmed.2021.822804] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ehrenpreis ED, Zhou Y. Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel disease. World J Gastroenterol 2017; 23(26): 4752-4758 [PMID: 28765696 DOI: 10.3748/wjg.v23.i26.4752] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
36 García MJ, Pascual M, Del Pozo C, Díaz-González A, Castro B, Rasines L, Crespo J, Rivero M. Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach. Sci Rep 2020;10:10731. [PMID: 32612137 DOI: 10.1038/s41598-020-67710-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Wang R, Ward MM. Epidemiology of axial spondyloarthritis: an update. Curr Opin Rheumatol 2018;30:137-43. [PMID: 29227352 DOI: 10.1097/BOR.0000000000000475] [Cited by in Crossref: 45] [Cited by in F6Publishing: 21] [Article Influence: 15.0] [Reference Citation Analysis]
38 Cui Z, Hou G, Meng X, Feng H, He B, Tian Y. Bidirectional Causal Associations Between Inflammatory Bowel Disease and Ankylosing Spondylitis: A Two-Sample Mendelian Randomization Analysis. Front Genet 2020;11:587876. [PMID: 33329731 DOI: 10.3389/fgene.2020.587876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Sanz Sanz J, Juanola Roura X, Seoane-mato D, Montoro M, Gomollón F. Criterios de cribado de enfermedad inflamatoria intestinal y espondiloartritis para derivación de pacientes entre Reumatología y Gastroenterología. Reumatología Clínica 2018;14:68-74. [DOI: 10.1016/j.reuma.2017.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Hammoudeh M, Elsayed E, Al-Kaabi S, Sharma M, Elbadri M, Chandra P, Abu Nahia N, Hammoudeh S. Rheumatic manifestations of inflammatory bowel diseases: A study from the Middle East. J Int Med Res 2018;46:3837-47. [PMID: 29961404 DOI: 10.1177/0300060518781404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
41 Cereser L, Zancan G, Giovannini I, Cicciò C, Tinazzi I, Variola A, Bramuzzo M, Murru FM, Marino M, Tullio A, De Vita S, Girometti R, Zabotti A. Asymptomatic sacroiliitis detected by magnetic resonance enterography in patients with Crohn's disease: prevalence, association with clinical data, and reliability among radiologists in a multicenter study of adult and pediatric population. Clin Rheumatol 2022. [PMID: 35389115 DOI: 10.1007/s10067-022-06143-w] [Reference Citation Analysis]
42 Ono K, Kishimoto M, Deshpande GA, Fukui S, Kawaai S, Sawada H, Matsuura M, Rodriguez VR, Proft F, Tada K, Tamura N, Taniguchi Y, Hirata A, Kameda H, Tsuji S, Kaneko Y, Dobashi H, Okano T, Haji Y, Morita A, Okada M, Komagata Y, Medina CL, Molto A, Dougados M, Hisamatsu T, Tomita T, Kaname S. Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis. Rheumatol Int. [DOI: 10.1007/s00296-022-05117-0] [Reference Citation Analysis]
43 Lefferts AR, Regner EH, Stahly A, O'Rourke B, Gerich ME, Fennimore BP, Scott FI, Freeman AE, Jones K, Kuhn KA. Circulating mature granzyme B+ T cells distinguish Crohn's disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn's disease. Arthritis Res Ther 2021;23:147. [PMID: 34022940 DOI: 10.1186/s13075-021-02531-w] [Reference Citation Analysis]